Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1954 1
1955 3
1956 4
1957 3
1961 4
1962 2
1963 3
1964 4
1965 7
1966 8
1967 11
1968 6
1969 7
1970 8
1971 11
1972 11
1973 9
1974 15
1975 19
1976 25
1977 24
1978 23
1979 16
1980 19
1981 29
1982 27
1983 28
1984 36
1985 44
1986 43
1987 43
1988 53
1989 68
1990 64
1991 70
1992 64
1993 66
1994 70
1995 85
1996 97
1997 111
1998 90
1999 94
2000 116
2001 103
2002 101
2003 111
2004 132
2005 142
2006 174
2007 135
2008 138
2009 154
2010 161
2011 154
2012 131
2013 140
2014 133
2015 157
2016 151
2017 155
2018 154
2019 152
2020 165
2021 91
Text availability
Article attribute
Article type
Publication date

Search Results

4,174 results
Results by year
Filters applied: . Clear all
Page 1
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.
Adams D, Gonzalez-Duarte A, O'Riordan WD, Yang CC, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, Lin KP, Vita G, Attarian S, Planté-Bordeneuve V, Mezei MM, Campistol JM, Buades J, Brannagan TH 3rd, Kim BJ, Oh J, Parman Y, Sekijima Y, Hawkins PN, Solomon SD, Polydefkis M, Dyck PJ, Gandhi PJ, Goyal S, Chen J, Strahs AL, Nochur SV, Sweetser MT, Garg PP, Vaishnaw AK, Gollob JA, Suhr OB. Adams D, et al. Among authors: ueda m. N Engl J Med. 2018 Jul 5;379(1):11-21. doi: 10.1056/NEJMoa1716153. N Engl J Med. 2018. PMID: 29972753 Free article. Clinical Trial.
[COVID-19 and stroke].
Wada K, Hashimoto Y, Nakajima M, Ueda M. Wada K, et al. Among authors: ueda m. Rinsho Shinkeigaku. 2020 Dec 26;60(12):822-839. doi: 10.5692/clinicalneurol.cn-001529. Epub 2020 Nov 20. Rinsho Shinkeigaku. 2020. PMID: 33229838 Review. Japanese.
Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus.
Kato Y, Park J, Takamatsu H, Konaka H, Aoki W, Aburaya S, Ueda M, Nishide M, Koyama S, Hayama Y, Kinehara Y, Hirano T, Shima Y, Narazaki M, Kumanogoh A. Kato Y, et al. Among authors: ueda m. Ann Rheum Dis. 2018 Oct;77(10):1507-1515. doi: 10.1136/annrheumdis-2018-212988. Epub 2018 Jun 26. Ann Rheum Dis. 2018. PMID: 29945921 Free PMC article.
Introduction.
Ando Y, Ueda M, Jono H. Ando Y, et al. Among authors: ueda m. Amyloid. 2019;26(sup1):1-3. doi: 10.1080/13506129.2019.1594184. Amyloid. 2019. PMID: 31343350 No abstract available.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Among authors: ueda m. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice.
Sugahara M, Tanaka S, Tanaka T, Saito H, Ishimoto Y, Wakashima T, Ueda M, Fukui K, Shimizu A, Inagi R, Yamauchi T, Kadowaki T, Nangaku M. Sugahara M, et al. Among authors: ueda m. J Am Soc Nephrol. 2020 Mar;31(3):560-577. doi: 10.1681/ASN.2019060582. Epub 2020 Jan 29. J Am Soc Nephrol. 2020. PMID: 31996409 Free PMC article.
4,174 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page